Libourne, France, 24th July 2012 :

Consolidated sales of the Ceva Group in the first half of 2012 were 303.7 M€, up by 17% on the same period 2011. The increase in sales was 15.5 % (excluding impact of exchange rates) and 13% in constant currencies. 

Virtuous growth in key products and countries

All the geographical zones progressed, with growth rates superior to 30% in North America and Asia-Pacific and more than 10% for the zones Central and Eastern Europe (including Turkey) and Africa-Middle East.

This remarkable performance further cements a trend of double-digit organic growth, based around the innovative core strategic products of the group:

Vaccines sales, mostly notably, Transmune and Vectormune, increased almost 30% in the first 6 months of 2012.

In the pharmaceutical sector, companion animal revenues increased +22.7% thanks to the success of the companion animal parasiticide, Vectra in the US and Feliway (behavior) in Europe and in the US. The livestock portfolio also posted strong double-digit growth of 10%, across all geographic zones, driven by the performance of injectable anti-infective, reproduction and anti-parasitic products.

The first half-year was also crucial for Ceva’s ambitions in China. The joint venture Ceva Huadu began trading as planned on January 1st 2012 and posted a performance in line with the business plan.

China is considered as a priority strategic market, in which the group will continue to invest. 

Several launches and geographical extensions of innovative products are planned for the 2nd half-year to support this trend of strong growth.

Marc Prikazsky, Chairman and Chief Executive Officer commented, “I am delighted to announce these excellent mid-year results, which confirm that our decision to focus on building key brands in key countries is the right one.  Our early engagement in emerging markets has helped but the fact that all zones are growing positively is a testament to the quality and commitment of our teams all over the world. Together, day by day, they transform our vision into reality and can be very proud of these results. ”

>> Click on the link below to download the Press Release :